Genome & Company Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	15,598	65,549	56,356	72,216	36,049
Short-Term Investments	12,510	8,227	18,863	28,205	35,249
Trading Asset Securities	8,722	7,155	11,053	6,278	5,865
Cash & Short-Term Investments	36,830	80,930	86,272	106,699	77,164
Cash Growth	-54.49%	-6.19%	-19.14%	38.28%	-29.59%
Accounts Receivable	1,855	2,060	1,402	1,957	759.22
Other Receivables	4,383	382.72	1,544	864.23	992.14
Receivables	6,238	2,442	2,946	2,821	1,751
Inventory	5,979	5,771	3,568	2,238	1,327
Prepaid Expenses	1,113	690.72	1,150	1,159	1,102
Other Current Assets	2,134	2,094	3,114	3,994	433.15
Total Current Assets	52,294	91,928	97,050	116,909	81,777
Property, Plant & Equipment	20,568	27,870	34,624	21,526	16,475
Long-Term Investments	-0	-	-	-	-
Goodwill	11,057	14,133	14,133	16,458	16,458
Other Intangible Assets	5,656	8,256	11,102	13,921	18,388
Other Long-Term Assets	55,433	5,148	5,152	4,182	4,119
Total Assets	145,008	147,335	162,060	172,997	137,216
Accounts Payable	509.05	481.2	340.19	205.18	321.4
Accrued Expenses	1,373	1,729	2,723	3,428	1,713
Short-Term Debt	15,325	18,401	12,634	-	-
Current Portion of Leases	1,316	1,228	1,055	2,024	1,583
Current Income Taxes Payable	0.15	-	-	-	-
Other Current Liabilities	4,115	7,973	12,131	5,484	6,208
Total Current Liabilities	22,638	29,812	28,883	11,141	9,826
Long-Term Debt	-	9,000	9,000	-	-
Long-Term Leases	2,326	3,395	3,764	4,267	5,243
Long-Term Deferred Tax Liabilities	2,180	3,242	4,414	5,582	6,826
Other Long-Term Liabilities	3,287	2,820	2,482	1,462	1,921
Total Liabilities	30,432	48,270	48,543	22,452	23,816
Common Stock	17,324	15,527	7,363	7,046	7,033
Additional Paid-In Capital	306,966	296,475	304,765	304,724	257,345
Retained Earnings	-311,199	-304,771	-284,659	-237,193	-185,355
Comprehensive Income & Other	87,992	40,198	34,240	21,784	13,710
Total Common Equity	101,083	47,428	61,708	96,360	92,733
Minority Interest	8,801	50,753	51,089	53,248	20,667
Shareholders' Equity	114,577	99,065	113,517	150,544	113,400
Total Liabilities & Equity	145,008	147,335	162,060	172,997	137,216
Total Debt	18,967	32,024	26,453	6,291	6,826
Net Cash (Debt)	17,862	48,906	59,819	100,408	70,338
Net Cash Growth	-63.48%	-18.24%	-40.42%	42.75%	-34.77%
Net Cash Per Share	569.66	1604.88	2118.26	3566.88	2616.46
Filing Date Shares Outstanding	32.17	31.05	29.45	28.18	28.13
Total Common Shares Outstanding	32.17	31.05	29.45	28.18	28.13
Working Capital	29,656	62,115	68,167	105,769	71,952
Book Value Per Share	3141.79	1527.27	2095.34	3419.08	3296.30
Tangible Book Value	84,370	25,040	36,473	65,981	57,888
Tangible Book Value Per Share	2622.32	806.31	1238.47	2341.16	2057.68
Land	1,819	2,699	2,710	10.59	-
Buildings	6,212	9,251	9,220	-	-
Machinery	17,591	18,063	15,838	14,662	9,167
Construction In Progress	2,692	2,503	8,492	4,245	2,262

Source: S&P Global Market Intelligence. Standard template. Financial Sources.